Found 23 matching trials
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer PHASE2 This study is an exploratory clinical trial to investigate the feasibility ...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC(AK104-IIT-13) PHASE2 This study is a single-arm, open-label, multicenter clinical study to evalu...
Show More Location
Multiple Locations
Learn More & Join Trial
Cadonilimab in Combination With Ramucirumab for the Treatment of Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy PHASE1 To evaluate the efficacy Cadonilimab in combination with Ramucirumab for th...
Show More Location
Tianjin Cancer Hospital Airport Hospital
Learn More & Join Trial
A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma PHASE3 A study to evaluate cadonilimab (AK104) + lenvatinib in combination with tr...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies PHASE1 Recombinant oncolytic adenovirus injection (KD01)is an oncolytic vius produ...
Show More Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer PHASE2 This is an open-label, multi-center Phase II study of cadonilimab (AK104) c...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Concurrent Chemoradiotherapy Followed by Cadonilimab(AK104) for Newly Diagnosed Local Advanced Cervical Cancer PHASE2 This study will evaluate the efficacy and safety of concurrent chemoradioth...
Show More Location
West China Second University Hospital
Learn More & Join Trial
Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis PHASE1 Leptomeningeal metastasis, characterized by tumor cells infiltrating and pr...
Show More Status
Active Not Recruiting
Location
The Affiliated Huizhou Hospital, Guangzhou Medical University
Learn More & Join Trial
Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC) PHASE1 Recombinant oncolytic adenovirus injection (KD01) is an oncolytic virus pro...
Show More Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours PHASE1 To evaluate the efficacy and safety of Cadonilimab Injection in combination...
Show More Location
Tianjin Cancer Hospital Airport Hospital
Learn More & Join Trial